Yi Ming Pharmaceutical announced that shareholder Zhou Zhan plans to reduce his stake by no more than 1% of the company's total shares. Separately, Rendu Bio announced that its controlling shareholder and actual controller, Ju Jinliang, along with other shareholders, are planning a share transfer that could lead to a change in control, prompting a trading halt. Additionally, Xiaomi's smartphone shipments have fallen out of the top five, with its automotive business potentially being a factor. AI
Summary written by gemini-2.5-flash-lite from 1 source. How we write summaries →
RANK_REASON This cluster contains multiple unrelated news items, including a shareholder announcement, a company control change, and a product market analysis, lacking a single coherent narrative.